View updated information about our visitor policy  »
Book an appointment at our COVID-19 Assessment Centre (new location) »

Hospital  >  News & media  >  News

Global COVID-19 treatment trial results published in the New England Journal of Medicine

December 3, 2020

SHARE

Interim results of the World Health Organization’s Solidarity Trial, the world’s largest randomized control trial on COVID-19 therapeutics, were published yesterday in the New England Journal of Medicine. The trial has generated conclusive evidence on the effectiveness of repurposed drugs for the treatment of COVID-19, and indicates that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients.

The Canadian arm of the Solidarity Therapeutics Trial, called the Canadian Treatments for COVID-19 (CATCO) trial, is led by Dr. Srinivas Murthy at the University of British Columbia in Vancouver and Dr. Robert Fowler at Sunnybrook.

Read more about the trial results